spacer
spacer

PDBsum entry 1tzh

Go to PDB code: 
protein Protein-protein interface(s) links
Immune system PDB id
1tzh

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
94 a.a. *
210 a.a. *
222 a.a. *
Waters ×110
* Residue conservation analysis
PDB id:
1tzh
Name: Immune system
Title: Crystal structure of the fab yads1 complexed with h-vegf
Structure: Vascular endothelial growth factor a. Chain: v, w. Synonym: vegf-a, vascular permeability factor, vpf, h-vegf. Engineered: yes. Fab yads1 light chain. Chain: a, l. Engineered: yes. Fab yads1 heavy chain. Chain: b, h.
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: vegf, vegfa. Expressed in: escherichia coli. Expression_system_taxid: 562. Mus musculus. House mouse. Organism_taxid: 10090.
Biol. unit: Hexamer (from PQS)
Resolution:
2.60Å     R-factor:   0.215     R-free:   0.271
Authors: F.A.Fellouse,C.Wiesmann,S.S.Sidhu
Key ref:
F.A.Fellouse et al. (2004). Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. Proc Natl Acad Sci U S A, 101, 12467-12472. PubMed id: 15306681 DOI: 10.1073/pnas.0401786101
Date:
09-Jul-04     Release date:   31-Aug-04    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P15692  (VEGFA_HUMAN) -  Vascular endothelial growth factor A, long form from Homo sapiens
Seq:
Struc:
395 a.a.
94 a.a.
Protein chains
No UniProt id for this chain
Struc: 210 a.a.
Protein chains
No UniProt id for this chain
Struc: 222 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 

 
DOI no: 10.1073/pnas.0401786101 Proc Natl Acad Sci U S A 101:12467-12472 (2004)
PubMed id: 15306681  
 
 
Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition.
F.A.Fellouse, C.Wiesmann, S.S.Sidhu.
 
  ABSTRACT  
 
Antigen-binding fragments (Fabs) with synthetic antigen-binding sites were isolated from phage-displayed libraries with restricted complementarity-determining region (CDR) diversity. Libraries were constructed such that solvent-accessible CDR positions were randomized with a degenerate codon that encoded for only four amino acids (tyrosine, alanine, aspartate, and serine). Nonetheless, high-affinity Fabs (K(d) = 2-10 nM) were isolated against human vascular endothelial growth factor (hVEGF), and the crystal structures were determined for two distinct Fab-hVEGF complexes. The structures revealed that antigen recognition was mediated primarily by tyrosine side chains, which accounted for 71% of the Fab surface area that became buried upon binding to hVEGF. In contrast, aspartate residues within the CDRs were almost entirely excluded from the binding interface. Alanine and serine residues did not make many direct contacts with antigen, but they allowed for space and conformational flexibility and thus played an auxiliary role in facilitating productive contacts between tyrosine and antigen. Tyrosine side chains were capable of mediating most of the contacts necessary for high-affinity antigen recognition, and, thus, it seems likely that the overabundance of tyrosine in natural antigen-binding sites is a consequence of the side chain being particularly well suited for making productive contacts with antigen. The findings shed light on the basic principles governing the evolution of natural immune repertoires and should also aid the development of improved synthetic antibody libraries.
 
  Selected figure(s)  
 
Figure 3.
Fig. 3. The structural epitope for binding to YADS1 (A) or YADS2 (B) mapped on the molecular surface of hVEGF. The structural epitope consists of hVEGF residues that make contact with one or more residues of the Fab, with "contact" defined as a distance <4.1 Å. Residues that contact the heavy or light chain are colored green or yellow, respectively. The dashed line outlines the structural epitope for binding to Flt-1[D2], as determined from a previously described x-ray structure (PDB code 1FLT [PDB] ) (34).
Figure 5.
Fig. 5. The CDR side chains of YADS1 (A) and YADS2 (B) that contact hVEGF. The structural epitope for binding to the Fab (see Fig. 3) was mapped onto the molecular surface of hVEGF, and residues that made contacts with tyrosines or other residue types are colored orange or blue, respectively. The side chains at CDR positions that were randomized in the libraries are shown. Side chains that do not make contact with hVEGF are colored white. Tyrosine side chains that make contacts with hVEGF are colored red, whereas all other contacting side chains are colored blue. The hVEGF molecules are shown in the same orientation in both panels.
 
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21390033 A.R.Bradbury, S.Sidhu, S.Dübel, and J.McCafferty (2011).
Beyond natural antibodies: the power of in vitro display technologies.
  Nat Biotechnol, 29, 245-254.  
21068165 D.Lipovsek (2011).
Adnectins: engineered target-binding protein therapeutics.
  Protein Eng Des Sel, 24, 3-9.  
21296164 N.Monroe, G.Sennhauser, M.A.Seeger, C.Briand, and M.G.Grütter (2011).
Designed ankyrin repeat protein binders for the crystallization of AcrB: Plasticity of the dominant interface.
  J Struct Biol, 174, 269-281.
PDB codes: 3noc 3nog
21365678 O.Sharabi, A.Dekel, and J.M.Shifman (2011).
Triathlon for energy functions: Who is the winner for design of protein-protein interactions?
  Proteins, 79, 1487-1498.  
21131908 S.Newstead, D.Drew, A.D.Cameron, V.L.Postis, X.Xia, P.W.Fowler, J.C.Ingram, E.P.Carpenter, M.S.Sansom, M.J.McPherson, S.A.Baldwin, and S.Iwata (2011).
Crystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2.
  EMBO J, 30, 417-426.
PDB code: 2xut
21151117 Y.Koldobskaya, E.M.Duguid, D.M.Shechner, N.B.Suslov, J.Ye, S.S.Sidhu, D.P.Bartel, S.Koide, A.A.Kossiakoff, and J.A.Piccirilli (2011).
A portable RNA sequence whose recognition by a synthetic antibody facilitates structural determination.
  Nat Struct Mol Biol, 18, 100-106.  
20067921 B.J.Hackel, and K.D.Wittrup (2010).
The full amino acid repertoire is superior to serine/tyrosine for selection of high affinity immunoglobulin G binders from the fibronectin scaffold.
  Protein Eng Des Sel, 23, 211-219.  
20007707 B.Li, L.Zhao, C.Wang, H.Guo, L.Wu, X.Zhang, W.Qian, H.Wang, and Y.Guo (2010).
The protein-protein interface evolution acts in a similar way to antibody affinity maturation.
  J Biol Chem, 285, 3865-3871.  
21103060 C.M.Brawley, S.Uysal, A.A.Kossiakoff, and R.S.Rock (2010).
Characterization of engineered actin binding proteins that control filament assembly and structure.
  PLoS One, 5, e13960.  
21077798 D.J.Martin, and M.Ramirez-Alvarado (2010).
Comparison of amyloid fibril formation by two closely related immunoglobulin light chain variable domains.
  Amyloid, 17, 129-136.  
20875152 D.Wu, J.Sun, T.Xu, S.Wang, G.Li, Y.Li, and Z.Cao (2010).
Stacking and energetic contribution of aromatic islands at the binding interface of antibody proteins.
  Immunome Res, 6, S1.  
20056614 L.Borras, T.Gunde, J.Tietz, U.Bauer, V.Hulmann-Cottier, J.P.Grimshaw, and D.M.Urech (2010).
Generic approach for the generation of stable humanized single-chain Fv fragments from rabbit monoclonal antibodies.
  J Biol Chem, 285, 9054-9066.  
21085650 M.P.Greving, P.E.Belcher, C.W.Diehnelt, M.J.Gonzalez-Moa, J.Emery, J.Fu, S.A.Johnston, and N.W.Woodbury (2010).
Thermodynamic additivity of sequence variations: an algorithm for creating high affinity peptides without large libraries or structural information.
  PLoS One, 5, e15432.  
20412054 M.Umetsu, T.Nakanishi, R.Asano, T.Hattori, and I.Kumagai (2010).
Protein-protein interactions and selection: generation of molecule-binding proteins on the basis of tertiary structural information.
  FEBS J, 277, 2006-2014.  
20383388 S.Birtalan, R.D.Fisher, and S.S.Sidhu (2010).
The functional capacity of the natural amino acids for molecular recognition.
  Mol Biosyst, 6, 1186-1194.  
20445236 Z.S.Derewenda (2010).
Application of protein engineering to enhance crystallizability and improve crystal properties.
  Acta Crystallogr D Biol Crystallogr, 66, 604-615.  
19477127 C.J.Farady, B.D.Sellers, M.P.Jacobson, and C.S.Craik (2009).
Improving the species cross-reactivity of an antibody using computational design.
  Bioorg Med Chem Lett, 19, 3744-3747.  
19208804 J.Gao, S.S.Sidhu, and J.A.Wells (2009).
Two-state selection of conformation-specific antibodies.
  Proc Natl Acad Sci U S A, 106, 3071-3076.  
19421748 T.Shibui, T.Kobayashi, K.Kanatani, H.Koga, S.Misawa, T.Isomura, and T.Sasaki (2009).
In vitro selection of scFv and its production: an application of mRNA display and wheat embryo cell-free and E. coli cell production system.
  Appl Microbiol Biotechnol, 84, 725-732.  
19913488 V.Burke, C.Williams, M.Sukumaran, S.S.Kim, H.Li, X.H.Wang, M.K.Gorny, S.Zolla-Pazner, and X.P.Kong (2009).
Structural basis of the cross-reactivity of genetically related human anti-HIV-1 mAbs: implications for design of V3-based immunogens.
  Structure, 17, 1538-1546.
PDB codes: 3ghb 3ghe
19615335 X.Xiao, Y.Feng, B.K.Vu, R.Ishima, and D.S.Dimitrov (2009).
A large library based on a novel (CH2) scaffold: identification of HIV-1 inhibitors.
  Biochem Biophys Res Commun, 387, 387-392.  
18210369 B.A.Manjasetty, A.P.Turnbull, S.Panjikar, K.Büssow, and M.R.Chance (2008).
Automated technologies and novel techniques to accelerate protein crystallography for structural genomics.
  Proteomics, 8, 612-625.  
18384812 C.W.Cobaugh, J.C.Almagro, M.Pogson, B.Iverson, and G.Georgiou (2008).
Synthetic antibody libraries focused towards peptide ligands.
  J Mol Biol, 378, 622-633.  
18393447 J.A.Boyer, and A.L.Lee (2008).
Monitoring aromatic picosecond to nanosecond dynamics in proteins via 13C relaxation: expanding perturbation mapping of the rigidifying core mutation, V54A, in eglin c.
  Biochemistry, 47, 4876-4886.  
18162543 J.D.Ye, V.Tereshko, J.K.Frederiksen, A.Koide, F.A.Fellouse, S.S.Sidhu, S.Koide, A.A.Kossiakoff, and J.A.Piccirilli (2008).
Synthetic antibodies for specific recognition and crystallization of structured RNA.
  Proc Natl Acad Sci U S A, 105, 82-87.
PDB code: 2r8s
18532877 J.L.Miller, J.Le Coq, A.Hodes, R.Barbalat, J.F.Miller, and P.Ghosh (2008).
Selective ligand recognition by a diversity-generating retroelement variable protein.
  PLoS Biol, 6, e131.
PDB code: 2iou
18656541 L.G.Presta (2008).
Molecular engineering and design of therapeutic antibodies.
  Curr Opin Immunol, 20, 460-470.  
18602117 R.N.Gilbreth, K.Esaki, A.Koide, S.S.Sidhu, and S.Koide (2008).
A dominant conformational role for amino acid diversity in minimalist protein-protein interfaces.
  J Mol Biol, 381, 407-418.
PDB codes: 3csb 3csg
17420456 A.Koide, R.N.Gilbreth, K.Esaki, V.Tereshko, and S.Koide (2007).
High-affinity single-domain binding proteins with a binary-code interface.
  Proc Natl Acad Sci U S A, 104, 6632-6637.
PDB code: 2obg
17452789 D.R.Cooper, T.Boczek, K.Grelewska, M.Pinkowska, M.Sikorska, M.Zawadzki, and Z.Derewenda (2007).
Protein crystallization by surface entropy reduction: optimization of the SER strategy.
  Acta Crystallogr D Biol Crystallogr, 63, 636-645.
PDB codes: 2bxw 2jhs 2jht 2jhu 2jhv 2jhw 2jhx 2jhy 2jhz 2ji0
17150020 G.Fuh (2007).
Synthetic antibodies as therapeutics.
  Expert Opin Biol Ther, 7, 73-87.  
17477812 I.Benhar (2007).
Design of synthetic antibody libraries.
  Expert Opin Biol Ther, 7, 763-779.  
17327672 O.Kirillova, M.Chruszcz, I.A.Shumilin, T.Skarina, E.Gorodichtchenskaia, M.Cymborowski, A.Savchenko, A.Edwards, and W.Minor (2007).
An extremely SAD case: structure of a putative redox-enzyme maturation protein from Archaeoglobus fulgidus at 3.4 A resolution.
  Acta Crystallogr D Biol Crystallogr, 63, 348-354.
PDB code: 2o9x
17962407 S.Nauli, S.Farr, Y.J.Lee, H.Y.Kim, S.Faham, and J.U.Bowie (2007).
Polymer-driven crystallization.
  Protein Sci, 16, 2542-2551.
PDB codes: 2qar 2qb0 2qb1
17500026 S.S.Sidhu, and A.A.Kossiakoff (2007).
Exploring and designing protein function with restricted diversity.
  Curr Opin Chem Biol, 11, 347-354.  
16484997 A.Whitty, and G.Kumaravel (2006).
Between a rock and a hard place?
  Nat Chem Biol, 2, 112-118.  
17023486 C.Kiss, H.Fisher, E.Pesavento, M.Dai, R.Valero, M.Ovecka, R.Nolan, M.L.Phipps, N.Velappan, L.Chasteen, J.S.Martinez, G.S.Waldo, P.Pavlik, and A.R.Bradbury (2006).
Antibody binding loop insertions as diversity elements.
  Nucleic Acids Res, 34, e132.  
16338215 J.A.McIntyre, D.R.Wagenknecht, and W.P.Faulk (2006).
Redox-reactive autoantibodies: detection and physiological relevance.
  Autoimmun Rev, 5, 76-83.  
16881059 J.C.Almagro, V.Quintero-Hernández, M.Ortiz-León, A.Velandia, S.L.Smith, and B.Becerril (2006).
Design and validation of a synthetic VH repertoire with tailored diversity for protein recognition.
  J Mol Recognit, 19, 413-422.  
17108986 S.S.Sidhu, and F.A.Fellouse (2006).
Synthetic therapeutic antibodies.
  Nat Chem Biol, 2, 682-688.  
16131663 G.Pál, S.Y.Fong, A.A.Kossiakoff, and S.S.Sidhu (2005).
Alternative views of functional protein binding epitopes obtained by combinatorial shotgun scanning mutagenesis.
  Protein Sci, 14, 2405-2413.  
16151404 H.R.Hoogenboom (2005).
Selecting and screening recombinant antibody libraries.
  Nat Biotechnol, 23, 1105-1116.  
16189008 R.A.Wilkinson, C.Piscitelli, M.Teintze, L.A.Cavacini, M.R.Posner, and C.M.Lawrence (2005).
Structure of the Fab fragment of F105, a broadly reactive anti-human immunodeficiency virus (HIV) antibody that recognizes the CD4 binding site of HIV type 1 gp120.
  J Virol, 79, 13060-13069.
PDB code: 1u6a
16252250 R.L.Rich, and D.G.Myszka (2005).
Survey of the year 2004 commercial optical biosensor literature.
  J Mol Recognit, 18, 431-478.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer